{"id":"anti-tnf-drug","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site reaction"},{"rate":"10-20%","effect":"Headache"},{"rate":"10-20%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL3897557","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"TNF-alpha is a cytokine that promotes inflammation and is involved in the pathogenesis of various autoimmune diseases. By blocking TNF-alpha, anti-TNF drugs reduce inflammation and alleviate symptoms in patients with conditions such as rheumatoid arthritis and psoriasis.","oneSentence":"Anti-TNF drugs block the action of tumor necrosis factor-alpha (TNF-alpha), a protein involved in systemic inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:10:22.749Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Psoriatic arthritis"},{"name":"Plaque psoriasis"}]},"trialDetails":[{"nctId":"NCT06654882","phase":"PHASE3","title":"Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-01-09","conditions":"Polyarticular Course Juvenile Idiopathic Arthritis (JIA)","enrollment":400},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT06812988","phase":"PHASE2","title":"Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-02-28","conditions":"Type 1 Diabetes Mellitus","enrollment":84},{"nctId":"NCT04936308","phase":"PHASE3","title":"Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-28","conditions":"Arthritis, Psoriatic","enrollment":453},{"nctId":"NCT04314531","phase":"PHASE3","title":"Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2020-07-01","conditions":"Active Psoriatic Arthritis","enrollment":296},{"nctId":"NCT07453628","phase":"","title":"Association of Erectile Dysfunction With Neuropathic Pain, Disease Activity, and Functional Status in Male Patients With Axial Spondyloarthritis: A Cross-Sectional Observational Study","status":"COMPLETED","sponsor":"Altuğ Güner","startDate":"2021-02-03","conditions":"Ankylosing Spondylitis, Sexual Dysfunction","enrollment":90},{"nctId":"NCT07280702","phase":"PHASE4","title":"Deucravacitinib-TNF Combination Therapy for Difficult-to-Control Psoriatic Disease","status":"NOT_YET_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-04-15","conditions":"Psoriatic Arthritis (PsA)","enrollment":128},{"nctId":"NCT05305066","phase":"NA","title":"Stand UP to Rheumatoid Arthritis (SUPRA)","status":"RECRUITING","sponsor":"Marie Hudson, MD","startDate":"2023-02-01","conditions":"Rheumatoid Arthritis","enrollment":75},{"nctId":"NCT06301477","phase":"NA","title":"PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Eastern Ontario","startDate":"2024-12-01","conditions":"Inflammatory Bowel Diseases, Crohn Disease","enrollment":45},{"nctId":"NCT07117344","phase":"","title":"Biomarkers in Ankylosing Spondylitis","status":"RECRUITING","sponsor":"Kirsehir Ahi Evran Universitesi","startDate":"2026-01-15","conditions":"Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)","enrollment":160},{"nctId":"NCT02829424","phase":"PHASE4","title":"Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis","status":"TERMINATED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2017-01-23","conditions":"Psoriasis","enrollment":78},{"nctId":"NCT05379322","phase":"PHASE3","title":"The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients","status":"WITHDRAWN","sponsor":"Abu Dhabi Stem Cells Center","startDate":"2023-03-01","conditions":"Rheumatoid Arthritis","enrollment":""},{"nctId":"NCT05428488","phase":"PHASE3","title":"Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2022-11-28","conditions":"Rheumatoid Arthritis","enrollment":220},{"nctId":"NCT07198113","phase":"","title":"COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-11-01","conditions":"Ulcerative Colitis, Pediatric, Inflammatory Bowel Diseases, Crohn Disease","enrollment":1100},{"nctId":"NCT02508012","phase":"NA","title":"Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2015-09-24","conditions":"Crohn's Disease, Ulcerative Colitis","enrollment":260},{"nctId":"NCT05781152","phase":"PHASE4","title":"Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease","status":"RECRUITING","sponsor":"Connecticut Children's Medical Center","startDate":"2023-06-10","conditions":"Crohn Disease","enrollment":900},{"nctId":"NCT07182630","phase":"","title":"Investigation Of The Effects Of Anti-Tnf-Α And Non-Tnf-Α Drugs İn Patients With Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Firat University","startDate":"2025-10-01","conditions":"Rheumatoid Arthritis (RA","enrollment":40},{"nctId":"NCT06925061","phase":"PHASE2","title":"Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease","status":"RECRUITING","sponsor":"Madeleine Bezault","startDate":"2025-03-31","conditions":"Crohn Disease (CD)","enrollment":80},{"nctId":"NCT01394276","phase":"","title":"An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-05","conditions":"Rheumatoid Arthritis","enrollment":322},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT04985435","phase":"PHASE4","title":"Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)","status":"RECRUITING","sponsor":"R.Bos","startDate":"2021-05-12","conditions":"Rheumatoid Arthritis","enrollment":100},{"nctId":"NCT06385522","phase":"PHASE1","title":"A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System","status":"NOT_YET_RECRUITING","sponsor":"Boston Immune Technologies and Therapeutics","startDate":"2025-08","conditions":"NHL, Cutaneous T Cell Lymphoma, Peripheral T-cell Lymphoma","enrollment":37},{"nctId":"NCT07041112","phase":"","title":"Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors","status":"COMPLETED","sponsor":"Juan Ruano Ruiz","startDate":"2012-01-01","conditions":"Psoriasis, Psoriatic Arthritis (PsA), Cardiovascular Risk Factors","enrollment":1000},{"nctId":"NCT03765450","phase":"","title":"Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alimentiv Inc.","startDate":"2018-12-21","conditions":"Ulcerative Colitis","enrollment":18},{"nctId":"NCT03681652","phase":"","title":"Post-Operative Crohn's Disease Outcome in Children","status":"RECRUITING","sponsor":"Schneider Children's Medical Center, Israel","startDate":"2019-02-11","conditions":"Crohn Disease","enrollment":100},{"nctId":"NCT03816397","phase":"PHASE4","title":"Adalimumab in JIA-associated Uveitis Stopping Trial","status":"COMPLETED","sponsor":"Nisha Acharya","startDate":"2020-03-15","conditions":"Uveitis, JIA","enrollment":87},{"nctId":"NCT02438787","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-07-31","conditions":"Axial Spondyloarthritis","enrollment":315},{"nctId":"NCT02437162","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-09-03","conditions":"Axial Spondyloarthritis","enrollment":347},{"nctId":"NCT06818045","phase":"NA","title":"Nonsurgical Periodontal Treatment Combined With Anti-TNF-α in Patients With Rheumatoid Arthritis and Periodontitis","status":"COMPLETED","sponsor":"Hatice Yemenoğlu","startDate":"2024-03-01","conditions":"Peridontal Disease, Rheumatic Arthritis","enrollment":46},{"nctId":"NCT06281106","phase":"PHASE2, PHASE3","title":"TYK2 Inhibition in Paradoxical Psoriasis","status":"TERMINATED","sponsor":"Prof Curdin Conrad","startDate":"2024-06-20","conditions":"Psoriasis","enrollment":2},{"nctId":"NCT06653634","phase":"PHASE4","title":"Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2024-10-24","conditions":"Juvenile Idiopathic Arthritis","enrollment":150},{"nctId":"NCT05197530","phase":"PHASE1","title":"Imaging of Lymphatic Vessels in People with Rheumatoid Arthritis (RA)","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2021-12-30","conditions":"Rheumatoid Arthritis","enrollment":40},{"nctId":"NCT05313620","phase":"PHASE4","title":"Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events","status":"RECRUITING","sponsor":"Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","startDate":"2022-04-01","conditions":"Ulcerative Colitis, Thromboembolism","enrollment":30},{"nctId":"NCT06862817","phase":"PHASE1, PHASE2","title":"Comparison Between the Effect of Aloe Vera and Benzydamine Hydrochloride Mouth Gel on Prevention of Pain and Progression of Radiation-induced Oral Mucositis","status":"COMPLETED","sponsor":"Minia University","startDate":"2023-11-01","conditions":"Radiation Indused Oral Mucositis","enrollment":30},{"nctId":"NCT06213857","phase":"PHASE2","title":"Beneficial Effect of Silymarin in Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-02-01","conditions":"Ulcerative Colitis","enrollment":44},{"nctId":"NCT03397108","phase":"","title":"Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2017-08-31","conditions":"Crohn's Disease, Ulcerative Colitis, Healthy Controls","enrollment":79},{"nctId":"NCT04505410","phase":"PHASE3","title":"Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"University of Miami","startDate":"2020-09-18","conditions":"Ulcerative Colitis","enrollment":32},{"nctId":"NCT03591770","phase":"PHASE4","title":"Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2019-07-31","conditions":"Inflammatory Bowel Diseases","enrollment":15},{"nctId":"NCT05090124","phase":"NA","title":"Experimental Medicine Studies of the Brain in Patients With Rheumatoid Arthritis REALISE","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2022-11-04","conditions":"Rheumatoid Arthritis","enrollment":46},{"nctId":"NCT04118556","phase":"PHASE2","title":"Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT","status":"RECRUITING","sponsor":"Mats Remberger","startDate":"2021-12-01","conditions":"GVHD, Acute","enrollment":50},{"nctId":"NCT02557308","phase":"","title":"An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis","status":"TERMINATED","sponsor":"Celltrion","startDate":"2015-05-26","conditions":"Ankylosing Spondylitis","enrollment":329},{"nctId":"NCT01706692","phase":"","title":"Swiss Dermatology Network of Targeted Therapies (SDNTT)","status":"RECRUITING","sponsor":"Swiss Dermatology Network for Targeted Therapies","startDate":"2011-02","conditions":"Psoriasis","enrollment":1121},{"nctId":"NCT03445845","phase":"PHASE4","title":"Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2018-12-14","conditions":"Axial Spondyloarthritis","enrollment":300},{"nctId":"NCT06269185","phase":"","title":"Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2024-03-06","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":271},{"nctId":"NCT04301128","phase":"NA","title":"The Effect of Mobile Application on Subcutaneous Anti-TNF Drug Administration:Ankylosing Spondylitis Patients","status":"COMPLETED","sponsor":"Eskisehir Osmangazi University","startDate":"2017-12-27","conditions":"Ankylosing Spondylitis, Spondylitis, Ankylosing","enrollment":32},{"nctId":"NCT04347798","phase":"","title":"IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2020-11-01","conditions":"Covid-19 Infection, Rheumatoid Arthritis, Psoriatic Arthritis","enrollment":773},{"nctId":"NCT04485325","phase":"PHASE4","title":"Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients","status":"COMPLETED","sponsor":"Dr. Frank Behrens","startDate":"2019-11-04","conditions":"Rheumatic Arthritis","enrollment":92},{"nctId":"NCT04725422","phase":"","title":"CHronic Nonbacterial Osteomyelitis International Registry","status":"RECRUITING","sponsor":"Seattle Children's Hospital","startDate":"2018-08-01","conditions":"Chronic Nonbacterial Osteomyelitis, Chronic Recurrent Multifocal Osteomyelitis","enrollment":2000},{"nctId":"NCT02469753","phase":"PHASE3","title":"Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2015-10-23","conditions":"Ankylosing Spondylitis","enrollment":188},{"nctId":"NCT02079441","phase":"","title":"Immune Function in Offsprings of Females With Inflammatory Bowel Disease","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2014-03","conditions":"Inflammatory Bowel Disease","enrollment":24},{"nctId":"NCT03652961","phase":"PHASE4","title":"Rheumatoid Arthritis Memory B Cells and Abatacept","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2019-06-02","conditions":"Rheumatoid Arthritis","enrollment":25},{"nctId":"NCT06441526","phase":"PHASE3","title":"Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-09-14","conditions":"Perianal Fistula, Crohn Disease","enrollment":94},{"nctId":"NCT01793519","phase":"PHASE4","title":"Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Georgetown University","startDate":"2013-01","conditions":"Rheumatoid Arthritis","enrollment":290},{"nctId":"NCT05447182","phase":"","title":"People-Powered Medicine (PPM): Rheumatoid Arthritis Non-responders to Biologic Therapies (RANT)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2021-07-06","conditions":"Rheumatoid Arthritis","enrollment":300},{"nctId":"NCT06177405","phase":"","title":"Predicting the Response of Patients With Rheumatoid Arthritis to Treatment With Genetically Engineered Biological Drugs and Janus (JAK) Kinase Inhibitors","status":"COMPLETED","sponsor":"Institute of Biomedical Chemistry, Russia","startDate":"2021-01-15","conditions":"Rheumatoid Arthritis","enrollment":50},{"nctId":"NCT05930613","phase":"PHASE3","title":"Certolizumab in Recurrent Implantation Failure (RIF)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-11-30","conditions":"Recurrent Unexplained Implantation Failure","enrollment":161},{"nctId":"NCT06144567","phase":"","title":"Response to Upadacitinib of Enthesitis Evaluated by Ultrasound in Patients With Psoriatic Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2023-12","conditions":"Psoriatic Arthritis","enrollment":19},{"nctId":"NCT05986903","phase":"","title":"Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.","status":"UNKNOWN","sponsor":"Hospital del Rio Hortega","startDate":"2023-01-11","conditions":"Drug Monitoring, Inflammatory Bowel Diseases","enrollment":280},{"nctId":"NCT02922192","phase":"","title":"Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis","status":"COMPLETED","sponsor":"Biologics & Biosimilars Collective Intelligence Consortium","startDate":"2012-01-01","conditions":"Rheumatoid Arthritis, Inflammatory Bowel Disease, Psoriasis","enrollment":90360},{"nctId":"NCT05931458","phase":"NA","title":"AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Federico II University","startDate":"2023-07-01","conditions":"Ulcerative Colitis","enrollment":94},{"nctId":"NCT02768532","phase":"PHASE4","title":"Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2016-07-01","conditions":"Crohn Disease","enrollment":47},{"nctId":"NCT05696106","phase":"","title":"Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-04-02","conditions":"Inflammatory Disease","enrollment":750000},{"nctId":"NCT03266471","phase":"","title":"Cytokines and Genes in Therapeutic Response in Crohn's Disease","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-10-13","conditions":"Inflammatory Bowel Diseases","enrollment":96},{"nctId":"NCT02772965","phase":"PHASE3","title":"Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2016-10","conditions":"Pediatric Crohn's Disease","enrollment":306},{"nctId":"NCT03808506","phase":"","title":"Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis","status":"WITHDRAWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2019-09-01","conditions":"Ulcerative Colitis","enrollment":""},{"nctId":"NCT04916847","phase":"","title":"Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-06-07","conditions":"Immune Response","enrollment":205},{"nctId":"NCT05540743","phase":"PHASE4","title":"Biologic Therapy in Pediatric JIA Uveitis","status":"UNKNOWN","sponsor":"Kasr El Aini Hospital","startDate":"2022-07-01","conditions":"Juvenile Idiopathic Arthritis Associated Uveitis","enrollment":250},{"nctId":"NCT03712826","phase":"NA","title":"Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease","status":"WITHDRAWN","sponsor":"Hospices Civils de Lyon","startDate":"2022-07-24","conditions":"Crohn Disease","enrollment":""},{"nctId":"NCT02552212","phase":"PHASE3","title":"Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS","status":"COMPLETED","sponsor":"UCB BIOSCIENCES GmbH","startDate":"2015-09","conditions":"Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis, Nr-axSpA","enrollment":317},{"nctId":"NCT01219257","phase":"","title":"Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy","status":"COMPLETED","sponsor":"Diakonhjemmet Hospital","startDate":"2011-09","conditions":"Spondyloarthritis, Ultrasonography","enrollment":50},{"nctId":"NCT02694588","phase":"NA","title":"Clinical and Molecular Phenotyping in IBD","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2014-06","conditions":"IBD","enrollment":90},{"nctId":"NCT01037907","phase":"PHASE2","title":"A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)","status":"TERMINATED","sponsor":"Boston Scientific Corporation","startDate":"2009-11","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":173},{"nctId":"NCT03419143","phase":"","title":"Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2018-03-02","conditions":"Psoriatic Arthritis (PsA)","enrollment":190},{"nctId":"NCT02821026","phase":"PHASE1, PHASE2","title":"Omental Islet Transplant","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2016-05","conditions":"Type 1 Diabetes","enrollment":4},{"nctId":"NCT01881308","phase":"PHASE4","title":"Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Diakonhjemmet Hospital","startDate":"2013-06-17","conditions":"Rheumatoid Arthritis","enrollment":320},{"nctId":"NCT03512275","phase":"PHASE2","title":"A Study of Bermekimab in Patients With Hidradenitis Suppurativa","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-06-20","conditions":"Hidradenitis Suppurativa","enrollment":42},{"nctId":"NCT05213767","phase":"PHASE1","title":"Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors","status":"UNKNOWN","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2022-02","conditions":"Advanced Tumors","enrollment":190},{"nctId":"NCT04729296","phase":"PHASE2","title":"Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D","status":"WITHDRAWN","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2021-07-01","conditions":"Diabetes Mellitus, Type 1","enrollment":""},{"nctId":"NCT04529902","phase":"","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - TNFi vs Abatacept","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-08-17","conditions":"Rheumatoid Arthritis","enrollment":63013},{"nctId":"NCT02538341","phase":"PHASE2","title":"Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2016-05","conditions":"Rheumatoid Arthritis, Inflammatory Arthritis, Arthritis","enrollment":617},{"nctId":"NCT05119452","phase":"NA","title":"Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2022-03","conditions":"Rheumatoid Arthritis","enrollment":85},{"nctId":"NCT01610947","phase":"NA","title":"Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2012-05-14","conditions":"Spondyloarthritis","enrollment":398},{"nctId":"NCT02930343","phase":"PHASE3","title":"Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy","status":"TERMINATED","sponsor":"Jawaharlal Institute of Postgraduate Medical Education & Research","startDate":"2016-09","conditions":"Rheumatoid Arthritis","enrollment":136},{"nctId":"NCT01064856","phase":"PHASE3","title":"Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2010-02","conditions":"Peripheral Spondyloarthritis","enrollment":165},{"nctId":"NCT04943237","phase":"","title":"Anti-TNF Therapy and Nerve Conduction Studies in Ankylosing Spondylitis","status":"COMPLETED","sponsor":"Istanbul Physical Medicine Rehabilitation Training and Research Hospital","startDate":"2019-07-01","conditions":"Anti - TNF Therapy, Ankylosing Spondylitis, Neuropathy","enrollment":60},{"nctId":"NCT01771809","phase":"PHASE2","title":"Long-Term Safety Of PF-00547659 In Ulcerative Colitis","status":"COMPLETED","sponsor":"Shire","startDate":"2013-03-18","conditions":"Ulcerative Colitis","enrollment":330},{"nctId":"NCT03452501","phase":"","title":"Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients","status":"COMPLETED","sponsor":"Hikma Pharmaceuticals LLC","startDate":"2018-08-26","conditions":"Inflammatory Bowel Diseases, Crohn Disease, Fistulizing Crohn's Disease","enrollment":157},{"nctId":"NCT02687620","phase":"","title":"Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study","status":"UNKNOWN","sponsor":"Izmir Katip Celebi University","startDate":"2014-09","conditions":"Ankylosing Spondylitis, Axial Spondyloarthritis","enrollment":180},{"nctId":"NCT03162796","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-08-24","conditions":"Arthritis, Psoriatic","enrollment":383},{"nctId":"NCT02505542","phase":"PHASE3","title":"Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo","status":"COMPLETED","sponsor":"UCB BIOSCIENCES GmbH","startDate":"2015-07","conditions":"Axial Spondyloarthrithis, Ankylosing Spondylitis","enrollment":736},{"nctId":"NCT03264703","phase":"","title":"Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World","status":"COMPLETED","sponsor":"Eisai Korea Inc.","startDate":"2017-09-11","conditions":"Arthritis, Rheumatoid","enrollment":212},{"nctId":"NCT01548768","phase":"PHASE4","title":"RHYTHM (Formerly Escape II Myocardium)","status":"COMPLETED","sponsor":"Columbia University","startDate":"2011-10-10","conditions":"Rheumatoid Arthritis","enrollment":149},{"nctId":"NCT03220841","phase":"PHASE4","title":"Stricture Definition and Treatment (STRIDENT) Drug Therapy Study","status":"UNKNOWN","sponsor":"St Vincent's Hospital Melbourne","startDate":"2017-10-09","conditions":"Crohn Disease, Inflammatory Bowel Diseases, Stricture; Bowel","enrollment":78},{"nctId":"NCT03378388","phase":"","title":"A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life","status":"TERMINATED","sponsor":"Takeda","startDate":"2018-02-13","conditions":"Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases","enrollment":29},{"nctId":"NCT04115423","phase":"","title":"A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab","status":"UNKNOWN","sponsor":"Sungkyunkwan University","startDate":"2020-04-01","conditions":"Infection, Rheumatoid Arthritis","enrollment":9508},{"nctId":"NCT03221166","phase":"PHASE3","title":"Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors","status":"TERMINATED","sponsor":"IRCCS Burlo Garofolo","startDate":"2018-02-27","conditions":"Crohn Disease","enrollment":9},{"nctId":"NCT03729674","phase":"","title":"Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2018-11-26","conditions":"Rheumatoid Arthritis, Ankylosing Spondylitis, Ulcerative Colitis","enrollment":800},{"nctId":"NCT04381598","phase":"PHASE2","title":"Stevia Rebaudiana Bertoni on Levels of GCF Glucose and Bio-markers in Diabetics.","status":"UNKNOWN","sponsor":"SVS Institute of Dental Sciences","startDate":"2019-04-01","conditions":"Periodontitis","enrollment":19},{"nctId":"NCT00175877","phase":"PHASE3","title":"A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-06","conditions":"Rheumatoid Arthritis","enrollment":857},{"nctId":"NCT03478111","phase":"PHASE3","title":"CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Shanghai Biomabs Pharmaceutical Co., Ltd.","startDate":"2018-03-30","conditions":"Rheumatoid Arthritis","enrollment":390}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":186,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Remicade","Remsima","Humira"],"phase":"phase_2","status":"active","brandName":"Anti-TNF Drug","genericName":"Anti-TNF Drug","companyName":"Schneider Children's Medical Center, Israel","companyId":"schneider-children-s-medical-center-israel","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anti-TNF drugs block the action of tumor necrosis factor-alpha (TNF-alpha), a protein involved in systemic inflammation. Used for Rheumatoid arthritis, Psoriatic arthritis, Plaque psoriasis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}